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In sports, diuretics are used for two main reasons: to ﬂush previously taken prohibited substances with
forced diuresis and in sports where weight classes are involved to achieve acute weight loss. A com-
mon property observed for thiazides is hydrolysis in aqueous media resulting in the formation of the
degradation product aminobenzenedisulphonamide. This degradation product can be observed for sev-
eral thiazides. Because there is limited information regarding the effect of pH, temperature and light on
the stability of thiazides, these parameters were investigated for chlorothiaizide, hydrochlorothiazideoping
rine
iuretics
hiazides
ports
tability-study
and altizide. For all three compounds the degradation product could be detected after incubation at pH
9.5 for 48h at 60 ◦C. At lower pH and temperature the degradation product could not be detected for all
compounds. When samples were exposed to UV-light altizide and hydrochlorothiazide were photode-
graded to chlorothiazide. When the degradation rate between the different compounds was compared
for a given temperature and pH, altizide is themost unstable compound. This study conﬁrms that thiazide
degradation products can be formed in urine during transport. Hence doping control laboratories shall
utineinclude them into their ro
. Introduction
Diuretics are an indispensable groupof therapeutics used to reg-
late the excretion of water and salts by increasing the urinary
ow. In sports they are used to ﬂush previously taken prohib-
ted substances with forced diuresis or, in sports where weight
lasses are involved, to achieve acute weight loss. Diuretics are
anned in sports by the World Anti-Doping Agency (WADA) [1]
nd cover a wide range of chemical products. A therapeutical
mportant group of diuretics are the thiazides (Table 1). Thiazides
over a whole class of structurally related compounds and have a
ommon structure consisting out of two fused heterocyclic rings
Table 1). Only a few thiazides are mentioned in the prohibited list
fWADA [1], i.e. bendroﬂumethiazide (BFMT), chlorothiazide (CLT)
ndhydrochlorothiazide (HCT).However, since theprohibited list is
ot limitative, doping control laboratories screen for a largenumber
f thiazides [2–5].
A commonproperty observed for thiazides is hydrolysis in aque-Please cite this article in press as: K. Deventer, et al., J. Pharm. Biomed. Ana
us media. This hydrolysis has been described ﬁrstly by Yamana et
l. [6] and in the framework of doping control analysis by Thieme
t al. [2]. Because of possible degradation in urine, Goebel et al.
3] highlighted the importance to include the degradation prod-
∗ Corresponding author. Tel.: +32 9 3313295; fax: +32 9 3313299.
E-mail address: koen.Deventer@UGent.be (K. Deventer).
URL: http://www.docolab.UGent.be (K. Deventer).
731-7085/$ – see front matter © 2008 Elsevier B.V. All rights reserved.
oi:10.1016/j.jpba.2008.11.001testing methods as required by WADA.
© 2008 Elsevier B.V. All rights reserved.
ucts into screening methods for diuretics. During hydrolysis the
substituent R3 is lost and a degradation product with a com-
mon skeleton is obtained (Table 1). This degradation product is
known as aminobenzenedisulphonamide (AB). Depending on the
functional groups R2, R4 and R6, in the parent thiazide different
degradationproducts canbe formed.Becausealtizide (ALT), CLTand
HCT only differ in substituent R3 a common degradation product,
aminochlorobenzenedisulphonamide (ACB), is obtained. Yamanaet
al. [6,7] found that both pH and temperature affected the degrada-
tion of CLT and HCT. In another study the reversibility and reaction
mechanism of HCT were further investigated [8]. All these stud-
ies were conducted at elevated temperatures (60 ◦C and 90 ◦C) in
aqueous buffers while no urinary matrices were investigated. An
approach at elevated temperature (100 ◦C) in a urinary matrix was
described for BFMT [9]. The authors focused on the long term pho-
todegradation (>20 days exposure to light) of bendroﬂumethiazide
at pH 5 and 7. They concluded that light has only a minor effect
on the degradation contrary to the important effect of pH. Another
study performed at our laboratory investigated the stability in uri-
nary matrices of several doping agents including thiazides [10].
The degradation of the thiazides was studied on a qualitative basis
without determination of degradation rates.l. (2008), doi:10.1016/j.jpba.2008.11.001
The aimof this studywas to determine the relationship between
degradation rate and pH or temperature, both in urinary and aque-
ous matrices. In contrast to the previous work this study was
performed at lower temperatures, e.g.: 20 ◦C, 40 ◦C and 60 ◦C. ALT,
CLT and HCT were investigated because both ALT and HCT are
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Table 1
Chemical structures and degradation products of several thiazide drugs.
R2 R3 R4 R6
Altizide (ALT) H H Cl
Chlorothiazide (CLT) H H 3,4 ene Cl
Hydrochlorothiazide (HCT) H H H Cl
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sendroﬂumethiazide (BFMT) H H
ydroﬂumethiazide (HFMT) H H H
ommercially available drugs on the Belgian market. CLT was also
ncluded because it can be detected as a metabolite of HCT and ALT
unpublished results). The results of this study could allow doping
ontrol authorities and doping control laboratories to consider crit-
cal parameters which can induce or increase degradation during
ransportation and sample preparation.
. Experimental
.1. Chemicals and reagents
HCT and CLT were obtained from Ciba-Geigy (Groot-Bijgaarden,
elgium), mefruside from Bayer Belgium (Brussels, Belgium) and
LT from Continental Pharma (Brussels). Acetazolamide was pur-
hased from Cyanamid Benelux (Brussels) and ACB was from
igma–Aldrich (Bornem, Belgium). Methanol p.a. (MeOH), formic
cid p.a. (HCOOH), HPLC grade acetonitrile (ACN) and HPLC grade
ater were from Acros (Geel, Belgium). Buffer pH 2.0 consisting of
.34 g citric acid trihydrate and 3.58g sodium chloride in 1 L aqua
idest, pH adjustmentwas performedwith hydrochloric acid (3M).
uffer pH 5.2: 68g sodium acetate dissolved in 1 L aqua bidest, pH
as adjusted using acetic acid. Buffer pH 7: 35.5 g disodiumhydro-
enphosphate dihydrate and 7.0 g sodiumdihydrogene phopshate
issolved in 500mL aqua bidest, pH adjusted with phosphoric acid
nd the buffer pH 9.2 was prepared by dissolving 200g ammonium
hloride in 500mL aqua bidest, pH was adjusted with ammonium
ydroxide (25%). All reagents for preparing the buffers were p.a.
rade from Merck (Darmstadt, Germany).
.2. Instrumentation
Temperature experiments were performed in a Heraeus labo-
atory oven (Liedekerke, Belgium) with a continuous temperature
ontrol. For the experiments under standard laboratory light con-
itions OSRAM ﬂuorscent lamps (58W) were used while the
xperiments under UV-light (Spectronics CM-26) were done at
56nm (intensity: 350W/cm2). Qualitative analyses were per-
ormed on an ion trap instrument using previously described
xperimental settings [5]. Semi-quantitative experiments were
one on a Quantum Discovery mass spectrometer (Thermo, San
ose, CA, USA) equippedwith an ESI source, operated in the positive
onisation mode.Please cite this article in press as: K. Deventer, et al., J. Pharm. Biomed. Ana
The ESI voltage was set to 3000V. Capillary temperature was
00 ◦C and the sheath gas ﬂow rate was arbitrary set at 70 units.
o auxilliary gas was used. The mass spectrometer was operated
n the SRM mode and the isolation width was set 0.7 FWHM. The
can speed and scanwidthweremaintained at 10ms and 0.01 amu,C F3
C F3
respectively. The collision gas pressure was 1.5mTorr for all the
compounds.
2.3. Experimental set-up
The stability study was divided into two parts: the ﬁrst part was
developed to determine the formation of ACB and was based upon
a qualitative set-up [10]. In the second part the degradation speed
was determined using a semi-quantitative approach [11].
In the qualitative part the three compounds were spiked in the
four buffers at a concentrationof 10g/mL. The solutionswere then
kept at 20 ◦C, 40 ◦C and 60 ◦C for 48h. Additionally, the experiments
at 20 ◦C were performed under laboratory light, daylight and UV
light (365nm). Afterwards the samples were cooled to 2 ◦C using
a Memmert cooling bath (Schwabach, Germany) and 50L mefru-
side solution (20g/mL) were added as internal standard. In the
semi-quantitative approach the three compounds were spiked in
triplicate at concentrations of 10g/mL in both urinary and aque-
ous matrices. For the experiments in water 1mL of bidest water
and 1mL of the buffer were mixed and for the experiments in uri-
nary matrix 1mL of urine and 1mL of the buffer. The samples were
evaluated at pH 5.2 and 7 (normal physiological range of urine) at
20 ◦C, 40 ◦C and 60 ◦C during 5h (300min). Aliquots were collected
after 30min, 60min, 90min, 120min, 150min, 180min, 210min,
240min, 270min and 300min exposure and cooled to 2 ◦C using
a Memmert cooling bath and 50L acetazolamide (20g/mL) was
added as internal standard.
2.4. Evaluation of the results
For the qualitative approach the evaluation of the results after-
wards was based upon three repetitions of every experiment. The
criterion for the detection was the presence of an ion trace in
the respective selected ion chromatogram with a signal-to-noise
(S/N) >3 at the expected retention time.
For the quantitative approach the average degradation speed
related to pH and temperature was calculated using a multiple lin-
ear regression model. The logarithmic area ratios (ln(ARs)) served
as dependent variables, and time and temperature and their inter-
actions were added as independent variables in the analysis. A
one-way analysis of variance (ANOVA) was used to detect differ-
ences in degradation speed over time.l. (2008), doi:10.1016/j.jpba.2008.11.001
Post hoc analyses were performed to determine which of the
degradation speeds differed between temperatures.
Regardless of the outcome of the ANOVA, it was tested if each
individual degradation speed differed from zero. Accounting for
multiple testing using the Dunn–Sidak correction, three (two)
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Table 2
Qualitative degradation experiments, shielded from light, during 48h at different pH and temperatures.
Compound pH 20 ◦C 40 ◦C 60 ◦C 20 ◦C 40 ◦C 60 ◦C
Detection parent Detection ACB
ALT
2.0 3/3a 3/3 3/3 ND 3/3 3/3
5.2 3/3 ND ND 3/3 3/3 3/3
7.0 ND ND ND 3/3 3/3 3/3
9.2 ND ND ND 3/3 3/3 3/3
HCT
2.0 3/3 3/3 3/3 ND ND 3/3
5.2 3/3 3/3 3/3 ND 3/3 3/3
7.0 3/3 3/3 3/3 3/3 3/3 3/3
9.2 3/3 3/3 ND 3/3 3/3 3/3
CLT
2.0 3/3 3/3 3/3 ND ND ND
5.2 3/3 3/3 3/3 ND ND ND
7.0 3/3 3/3 3/3 ND ND ND
N
9
d
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3
f
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H
C
1
D9.2 3/3 3/3
D: not detected.
a Number of positive detection/total number of repetitions of the experiment.
8.30% (97.47%) conﬁdence intervals were calculated, one for the
egradationspeedateach temperature.Alongsideof theconﬁdence
ntervals, the corresponding p-values are reported as well.
. Results and discussionPlease cite this article in press as: K. Deventer, et al., J. Pharm. Biomed. Ana
.1. Qualitative experiments
The results of the qualitative experiments, performed shielded
rom light, are presented in Table 2. At pH 2.0 all parent compounds
able 3
ualitative degradation experiments, shielded from light, during 2h at 60 ◦C.
ompound pH 60 ◦C
Detection parent Detection ACB
ALT
2.0 3/3a ND
5.2 3/3 3/3
7.0 3/3 3/3
9.2 ND 3/3
HCT
2.0 3/3 ND
5.2 3/3 ND
7.0 3/3 3/3
9.2 3/3 3/3
CLT
2.0 3/3 ND
5.2 3/3 ND
7.0 3/3 ND
9.2 3/3 3/3
D: not detected.
a Number of positive detection/total number of repetitions of the experiment.
able 4
tatistical analysis of the regression slopes comparing different temperatures.
pH R2 ANOVA (p)
LT
7 0.9870 1.95×10−44
1–2 5.13×10−12
1–3 4.60×10−44
2–3 2.16×10−33
CT
7 0.9121 0.6876
LT
7 0.9779 0.3862
: 20 ◦C; 2: 40 ◦C; 3: 60 ◦C. Conﬁdence intervals and p-values (except those for the ANO
unn–Sidak correction.ND 3/3 3/3 3/3
were still present in the samples after 48h incubation at 20 ◦C, 40 ◦C
and60 ◦C. For bothALT andHCT, ACBwasdetected indicatingdegra-
dation. ACB was observed for ALT at all temperatures whereas for
HCT only at 40 ◦C and 60 ◦C. For CLT, ACB was not detected at any
temperature.
After incubation at pH 5.2, ALT could no longer be detected at
40 ◦C and 60 ◦C but ACB was present in all samples. For HCT, ACB
was present at 40 ◦C and 60 ◦C and CLTwas stable at all the temper-
atures.
At pH 7.0 ALT was completely degraded at all temperatures. On
the other hand, HCT and CLT were still present in all samples and
no ACB could be detected for CLT in any of the samples. At pH
9.2 degradation seemed to be faster as for both HCT and CLT, ACB
was detected at all temperatures. At this pH none of the parent
substances could be detected at 60 ◦C. These experiments clearly
show that the combination of high temperature and pH results in
a faster degradation which was also observed in the BFMT-study
[9].
Because storage at 60 ◦C had a pronounced effect on the degra-
dation in the ﬁrst experiments (Table 2), degradation during a short
time period (2h) at this temperature was investigated as well. The
results are presented in Table 3. Even after this short time interval
the degradation product could already be detected at elevated tem-
perature and pH. ALT could no longer be detected at pH 9.2. Both
CLT and HCT were detectable in all situations.l. (2008), doi:10.1016/j.jpba.2008.11.001
When the experiments performed at 20 ◦C were conducted
under artiﬁcial laboratory light or daylight the same results were
obtained. Further, in the samples containingALT andHCT, a peak for
CLT was detected at pH 2 (Fig. 1). At higher pH values this peak was
Slopes: 98.30% BI p-Value
1 [−1.5×10−3; −4.2×10−4] 1.43×10−4
2 [−4.2×10−3; −3.1×10−3] 1.53×10−26
3 [−1.1×10−2; −9.6×10−3] 5.10×10−59
1 [−1.3×10−4; 8.7×10−5] 0.606
2 [−2.3×10−4; −6.8×10−6] 1.14×10−2
3 [−3.2×10−4; −9.6×10−5] 2.11×10−2
1 [−2.8×10−4; 1.5×10−4] 0.855
2 [−1.2×10−4; 3.0×10−4] 0.655
3 [−1.3×10−4; 2.9×10−4] 0.745
VA, but including the post hoc tests) were corrected for multiple testing using a
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wFig. 1. Extracted ion chromatograms for ACB, CLT, HCT and ALT in a refer
ot detected. Additionally, another set of samples was exposed to
VA light (365nm) during 48h. The outcomewas similar as for thePlease cite this article in press as: K. Deventer, et al., J. Pharm. Biomed. Ana
xperiments performed under daylight and CLT was only detected
t pH2.0 forHCT andALT. To the best of our knowledge such a trans-
ormation from ALT into CLT has not been previously reported. For
CT and BFMT photodegradation has been reported when samples
ere exposed to UVA light [9,12].ample (a) and a sample containing ALT exposed to daylight for 48h (b).
3.2. Semi-quantitative experimentsl. (2008), doi:10.1016/j.jpba.2008.11.001
Stability studies are an important topic in theﬁeldof anti-doping
analysis to ascertain the detection of all substances and to guaran-
tee reproducible inter- and intra-laboratory results. Unfortunately
few criteria for stability testing protocols are available. In 2004,
Jimenez et al. [11] described a practical approach for this purpose.
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FFig. 2. Degradation rate of altizide in water at pH 7.
he authors stated that stability studies, measuring concentrations
n time, can be hampered by poor reproduciblity of the analytical
ethod, in particular when ad hoc quantitativemethods are devel-
ped for the stability studies. Jimenez et al. showed that acceptable
esults can be achieved, using a qualitative method and comparing
he response (signal), given as the ARs of the analyte to the inter-
al standard, with a reference stored under conditions where no
egradation is observed. Since no quantitative method was avail-
ble for the investigated thiazides the latter approach was applied.
he references (without degradation) were the aliquots at t0. By
aking samples from this aliquot at several time points degradation
ates were measured by determining if the slopes deviated from
ero (Table 4).
Taking into account a previous studyon thedegradation of BFMT
nd the suggested ﬁrst order mechanism [9] linear curves were
tted through the logarithmic ARs. E[ln(ARs)t] = ln(ARs)t0 + kt,
here E[ln(ARs)t] denotes the average ln(ARs)t at time t among
ubjects with baseline level ln(ARs)t0 , with k=degradation speed;
0 = start of the degradation; t=degradation at a certain time
oint.Please cite this article in press as: K. Deventer, et al., J. Pharm. Biomed. Ana
This ﬁnal model was found to yield sufﬁciently high multiple
orrelation coefﬁcients of an average 98%,with the exception of one
ase where the correlation coefﬁcient was about 91%. There was no
orrection for multiple testing across experiments when perform-
ng the model comparison using ANOVA, as this would only affect
ig. 3. Comparison of the degradation rate in urine and water for altizide at 60 ◦C.Fig. 4. Comparison of degradation rate for ALT, CLT and HCT at pH 7.
the outcome of one case, where themultiple correlation coefﬁcient
reported was the lowest (91%).
Comparing the slopes for ALT at 20 ◦C, 40 ◦C and 60 ◦C inwater at
pH 7 a clear difference in degradation speed was found (Fig. 2). The
fastest degradation was observed at 60 ◦C and could be expected
compared to the qualitative experiments (vide supra). At 60 ◦C and
pH 7 half of the initial amount of ALT is lost after 82min in the
water samples. The linear trend analysis for the different slopes
showed that they all three were signiﬁcantly different from zero
(Table 4). For HCT similar ﬁrst order degradation kinetics as for ALT
were observed and signiﬁcant degradation was found at 40 ◦C and
60 ◦C (Table 4). At 20 ◦C no degradation was detected. For CLT none
of the slopes differed signiﬁcantly from zero (Table 4) and there-
fore no degradation was found under the described experimental
conditions.
Comparingdegradation speedbetweenpH5.2 and7.0 for a given
temperature yielded only for ALT a signiﬁcant difference at 60 ◦C.
For HCT and CLT no difference was detected at any temperature.
When urinary and aqueous matrices were compared the slopes
of the curves in water were signiﬁcantly steeper than those
obtained in urine (Fig. 3). This faster degradation in water has also
been found in the photodegradation study of BFMT [9].
Asdescribed in thequalitative experiments the formationofACB
was also observed. Unfortunately, no linear correlation for this for-
mation after plotting time versus ARs, ln(ARs) or 1/ARs was found.
Two possibilities were suggested for this non-linear behaviour: the
instability of ACB, or the linear range of the mass spectrometer
was exceeded. Both hypotheses were investigated and none could
explain this observation.
Finally, the plot of the degradation curves for the three sub-
stances at pH 7 and 60 ◦C (Fig. 4) clearly showed that ALT had the
highest degradation rate, CLT is themost stable and the degradation
speed for HCT lies in between.
4. Conclusion
This study has indicated that thiazide diuretics are subject tol. (2008), doi:10.1016/j.jpba.2008.11.001
degradation to a different extent depending on pH, light and tem-
perature. At pH 2 thiazide drugs were fairly stable even at elevated
temperatures. The thiazide drugs degrade faster at higher pH val-
ues.
 INP
6 cal an
d
c
s
t
t
e
m
d
t
s
R
a
o
A
Y
M
eARTICLEG ModelBA-7018; No.of Pages6
K. Deventer et al. / Journal of Pharmaceuti
Therefore it is recommended to cool or freeze urine samples
uring transport and storage.
As observed during the qualitative experiments chlorothiazide
an be formed from altizide and hydrochlorothiazide after expo-
ure to UVA light. This photodegradation is of lesser importance in
he anti-doping ﬁeld where samples are only exposed to labora-
ory light for a short time. The substances investigated in this study
xhibited different degradation rates and altizide seemed to be the
ost unstable one. Aspreviously observed for bendroﬂumethiazide
egradation in urine was slower than in aqueousmedia. The statis-
ical model applied in this work can also be useful to evaluate the
tability for other compounds without the need for quantitation.
esearch investigating the detection of the degradation product
minochlorobenzenedisulphonamide in administration urines is
ngoing.
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